Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer by Carolyn Helms | May 4, 2021 | Portfolio News
Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer by Carolyn Helms | May 4, 2021 | Portfolio News
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma by Carolyn Helms | May 4, 2021 | Portfolio News
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors by Carolyn Helms | Apr 13, 2021 | Portfolio News
Cohere Health gains $36M to expand digital prior authorization platform by Carolyn Helms | Apr 13, 2021 | Portfolio News
